Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2024-03-25
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Muscle Repair Following Exercise in Young and Elderly People
NCT02174692
Aging and the Mitochondrial Response to Exercise Training, Measured by Noninvasive 31P Magnetic Resonance Spectroscopy
NCT04799171
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women
NCT03888040
Effects of Resistance and Endurance Training on Synthesis of Individual Muscle Proteins in Young and Older Adults
NCT01489930
Effects of Eccentric Training at Long Muscle Length on Functional Capacities of Elderly Adults
NCT06953258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young, sedentary participants
* Aged between 18-30 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
Maximal exercise test
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
3D Ultrasound
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
Dynamometry
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Exercise test and occlusions
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise test in MRI
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].
Muscle biopsy
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Young endurance-trained participants
* Aged between 18-30 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports (i.e. running, cycling, swimming, triathlon, etc.)
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
Maximal exercise test
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
3D Ultrasound
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
Dynamometry
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Exercise test and occlusions
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise test in MRI
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].
Muscle biopsy
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Middle-aged, sedentary participants
* Aged between 50-65 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
Maximal exercise test
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
3D Ultrasound
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
Dynamometry
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Exercise test and occlusions
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise test in MRI
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].
Muscle biopsy
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Middle-aged endurance-trained participants
* Aged between 50-65 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports (i.e. running, cycling, swimming, triathlon, etc.)
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
Maximal exercise test
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
3D Ultrasound
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
Dynamometry
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Exercise test and occlusions
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise test in MRI
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].
Muscle biopsy
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maximal exercise test
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
3D Ultrasound
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
Dynamometry
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Exercise test and occlusions
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise test in MRI
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].
Muscle biopsy
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18-30 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
In order to be eligible to participate in this study, young trained participants must meet all of the following criteria:
* Aged between 18-30 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
In order to be eligible to participate in this study, older sedentary participants must meet all of the following criteria:
* Aged between 50-65 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
In order to be eligible to participate in this study, older trained participants must meet all of the following criteria:
* Aged between 50-65 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise
Exclusion Criteria
* Inability to provide informed consent
* History of claustrophobia
* Ineligibility to perform the exercise test described in this study protocol or follow instructions
* Taking any medications known to interfere with the physiological responses to exercise, e.g. e.g. systemic corticosteroids, statins, SGLT2 inhibitors, GLP1 receptor agonists
* Contraindication for MRI (e.g. pacemaker, claustrophobia)
* Being under investigation for non-diagnosed disease at the time of investigation
* Body Mass Index (BMI) \>30 due to adiposity, since this is known to cause difficulties in obtaining muscle biopsies and NIRS measurements
* Pregnancy
* Are current smokers or have been a regular smoker within the last 12 months
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VU University of Amsterdam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Richie Goulding
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richie Goulding, PhD
Role: PRINCIPAL_INVESTIGATOR
VU University of Amsterdam
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vrije Universiteit Amsterdam
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023.0746
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.